WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma

被引:0
|
作者
Nicholas Coupe
Lina Guo
Esther Bridges
Leticia Campo
Olivia Espinosa
Richard Colling
Andrea Marshall
Ashwin Nandakumar
Ruud van Stiphout
Francesca M. Buffa
Pippa G. Corrie
Mark R. Middleton
Valentine M. Macaulay
机构
[1] University of Oxford,Department of Oncology
[2] Oxford University Hospitals NHS Foundation Trust,Department of Oncology, Oxford Cancer and Haematology Centre
[3] Churchill Hospital,Department of Cellular Pathology
[4] Oxford University Hospitals NHS Foundation Trust,Warwick Clinical Trials Unit, Division of Health Sciences
[5] John Radcliffe Hospital,Nuffield Department of Surgical Sciences
[6] University of Warwick,Department of Oncology
[7] University of Oxford,undefined
[8] Cambridge University Hospitals NHS Foundation Trust,undefined
[9] Addenbrooke’s Hospital,undefined
来源
Cellular Oncology | 2023年 / 46卷
关键词
Melanoma; BRAF; Bevacizumab; ROR2; WNT5A;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:391 / 407
页数:16
相关论文
共 50 条
  • [41] Wnt5a/Ror2 promotes Nrf2-mediated tissue protective function of astrocytes after brain injury
    Endo, Mitsuharu
    Tanaka, Yuki
    Fukuoka, Mayo
    Suzuki, Hayata
    Minami, Yasuhiro
    GLIA, 2024, 72 (02) : 411 - 432
  • [42] Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
    Hauschild, Axel
    Ascierto, Paolo A.
    Schadendorf, Dirk
    Grob, Jean Jacques
    Ribas, Antoni
    Kiecker, Felix
    Dutriaux, Caroline
    Demidov, Lev V.
    Lebbe, Celeste
    Rutkowski, Piotr
    Blank, Christian U.
    Gutzmer, Ralf
    Millward, Michael
    Kefford, Richard
    Haas, Tomas
    D'Amelio, Anthony, Jr.
    Gasal, Eduard
    Mookerjee, Bijoyesh
    Chapman, Paul B.
    EUROPEAN JOURNAL OF CANCER, 2020, 125 : 114 - 120
  • [43] Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway
    Luo, Xing
    Duan, Yi
    He, Jinwei
    Huang, Conggai
    Liu, Jun
    Liu, Yifan
    Xu, Mengdei
    Dai, Qiong
    Yang, Zhihui
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [44] 肝细胞癌中Wnt-5a、Ror2蛋白的表达及临床意义
    江慧
    刘晓红
    曹志新
    曹永成
    毕利泉
    耿明
    临床与实验病理学杂志, 2010, 26 (06) : 652 - 654+661
  • [45] Down-regulation of PCBP2 suppresses the invasion and migration of trophoblasts via the WNT5A/ROR2 pathway in preeclampsia
    Chen, Zhenlie
    Zhong, Wen
    Zhang, Ruiqing
    Li, Guigui
    Zhang, Yuanzhen
    Zhang, Ming
    BIOLOGY OF REPRODUCTION, 2024, 111 (05) : 1142 - 1155
  • [46] The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells
    Hegedus, Luca
    Garay, Tamas
    Molnar, Eszter
    Varga, Karolina
    Bilecz, Agnes
    Torok, Szilvia
    Padanyi, Rita
    Paszty, Katalin
    Wolf, Matthias
    Grusch, Michael
    Kallay, Eniko
    Doeme, Balazs
    Berger, Walter
    Hegedus, Balazs
    Enyedi, Agnes
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (12) : 2758 - 2770
  • [47] circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling
    Wan, Jun
    Liu, Yupeng
    Long, Feng
    Tian, Jian
    Zhang, Can
    CANCER SCIENCE, 2021, 112 (05) : 1707 - 1722
  • [48] Spatiotemporal distribution analyses of Wnt5a ligand and its receptors Ror2, Frizzled2, and Frizzled5 during tongue muscle development in prenatal mice
    Asada, Naomi
    Suzuki, Kingo
    Sunohara, Masataka
    ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2023, 245
  • [49] KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma
    Ferrucci, Pier Francesco
    Di Giacomo, Anna Maria
    Del Vecchio, Michele
    Atkinson, Victoria
    Schmidt, Henrik
    Schachter, Jacob
    Queirolo, Paola
    Long, Georgina, V
    Stephens, Rosalie
    Svane, Inge Marie
    Lotem, Michal
    Abu-Amna, Mahmoud
    Gasal, Eduard
    Ghori, Razi
    Diede, Scott J.
    Croydon, Elizabeth S.
    Ribas, Antoni
    Ascierto, Paolo Antonio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [50] A plain language summary of the 5-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma
    Dummer, Reinhard
    Flaherty, Keith T.
    Robert, Caroline
    Arance, Ana
    de Groot, Jan Willem B.
    Garbe, Claus
    Gogas, Helen J.
    Gutzmer, Ralf
    Krajsova, Ivana
    Liszkay, Gabriella
    Loquai, Carmen
    Mandala, Mario
    Schadendorf, Dirk
    Yamazaki, Naoya
    di Pietro, Alessandra
    Cantey-Kiser, Jean
    Edwards, Michelle
    Ascierto, Paolo A.
    FUTURE ONCOLOGY, 2023, 19 (16) : 1091 - 1098